IE49712B1 - 2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application - Google Patents

2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application

Info

Publication number
IE49712B1
IE49712B1 IE899/80A IE89980A IE49712B1 IE 49712 B1 IE49712 B1 IE 49712B1 IE 899/80 A IE899/80 A IE 899/80A IE 89980 A IE89980 A IE 89980A IE 49712 B1 IE49712 B1 IE 49712B1
Authority
IE
Ireland
Prior art keywords
pyridinol
compound
general formula
formula
integer
Prior art date
Application number
IE899/80A
Other languages
English (en)
Other versions
IE800899L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE800899L publication Critical patent/IE800899L/xx
Publication of IE49712B1 publication Critical patent/IE49712B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IE899/80A 1979-05-03 1980-05-02 2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application IE49712B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03

Publications (2)

Publication Number Publication Date
IE800899L IE800899L (en) 1980-11-03
IE49712B1 true IE49712B1 (en) 1985-11-27

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
IE899/80A IE49712B1 (en) 1979-05-03 1980-05-02 2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application

Country Status (19)

Country Link
EP (1) EP0019739B1 (Direct)
JP (1) JPS55149260A (Direct)
AT (1) ATE8501T1 (Direct)
DD (1) DD150461A5 (Direct)
DE (1) DE3068577D1 (Direct)
DK (1) DK157540C (Direct)
ES (1) ES491055A0 (Direct)
FI (1) FI70212C (Direct)
GB (1) GB2050380B (Direct)
GR (1) GR68206B (Direct)
HU (1) HU181115B (Direct)
IE (1) IE49712B1 (Direct)
IL (1) IL59978A (Direct)
MA (1) MA18964A1 (Direct)
NO (1) NO154130C (Direct)
OA (1) OA06528A (Direct)
PL (1) PL223984A1 (Direct)
PT (1) PT71176A (Direct)
ZW (1) ZW9680A1 (Direct)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (ja) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 電子時計の電池保持構造

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
DE3068577D1 (en) 1984-08-23
EP0019739B1 (de) 1984-07-18
ATE8501T1 (de) 1984-08-15
PT71176A (en) 1980-05-01
FI70212B (fi) 1986-02-28
JPS55149260A (en) 1980-11-20
FI70212C (fi) 1986-09-15
ZW9680A1 (en) 1980-11-26
DK157540C (da) 1990-06-11
JPS6365662B2 (Direct) 1988-12-16
NO801267L (no) 1980-11-04
EP0019739A1 (de) 1980-12-10
DD150461A5 (de) 1981-09-02
IL59978A (en) 1984-03-30
IL59978A0 (en) 1980-07-31
GB2050380A (en) 1981-01-07
HU181115B (en) 1983-06-28
NO154130B (no) 1986-04-14
MA18964A1 (fr) 1980-12-31
DK193180A (da) 1980-11-04
DK157540B (da) 1990-01-22
NO154130C (no) 1986-07-23
ES8104229A1 (es) 1981-04-01
IE800899L (en) 1980-11-03
ES491055A0 (es) 1981-04-01
PL223984A1 (Direct) 1981-02-13
GB2050380B (en) 1983-07-20
FI801411A7 (fi) 1980-11-04
GR68206B (Direct) 1981-11-10
OA06528A (fr) 1981-07-31

Similar Documents

Publication Publication Date Title
US3920728A (en) Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
NO125723B (Direct)
NO167658B (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive difenylpropylaminderivater.
IE47996B1 (en) 6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines
IE47481B1 (en) 1-piperidinophthalazine cardiac stimulants
JPS6123790B2 (Direct)
CS205087B2 (en) Method of producing hydroxy-and oxoderivatives of aryloxy-and arylthio-perhydro-aza heterocycles
JP4383166B2 (ja) 新規なテトラヒドロイソキノリン類
US4260619A (en) 2-Aminoalkyl-5-pyridinols
GB2055360A (en) Benzimidazoles
EP0028698B1 (en) Quinoline compounds, process for their preparation, and pharmaceutical compositions
CZ289058B6 (cs) Aryl-benzoylguanidiny
US4010202A (en) 5,6-Dihydroxy aminotetralol compounds
US4350685A (en) Antiallergic imidodisulfamides
US4329367A (en) 1-(Aralkoxyphenyl)-2-(bis-arylalkylamino)-alkanes
CA1135269A (en) 2-aminoalkyl-5-pyridinols, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
GB2050360A (en) 2-Aminoalkyl-5-pyridinols
FI70212B (fi) Analogifoerfarande foer framstaellning av terapeutiskt aktiva 2-aminoalkyl-5-pyridinoler
US4296115A (en) Pyridylalkylamines
US4385047A (en) Antiallergic imidodisulfamides
US4091103A (en) Quinolyl or isoquinolyl-lower-alkoxy-phenylene-amino derivatives
US3228976A (en) 1, 4-bis-(aminomethyl)-1-cyclohexene compounds
CZ288609B6 (cs) Derivát alkenylbenzoylguanidinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
US4104402A (en) 5,6-Dihydroxy aminotetralol compounds
US20040133001A1 (en) Peptide deformylase inhibitors

Legal Events

Date Code Title Description
MM4A Patent lapsed